Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) ROCE % : 6.54% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hebei Changshan Biochemical Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 6.54%.

Hebei Changshan Biochemical Pharmaceutical Co ROCE % Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co ROCE % Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

11.17

12.08

9.75

2.89

-32.80

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-22.14	-102.88	-6.01	6.45	6.54

Hebei Changshan Biochemical Pharmaceutical Co ROCE % Calculation

Hebei Changshan Biochemical Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-1135.281	/	( ( (6035.803 - 1787.946)	+	(4596.454 - 1920.921) )	/ 2 )
	=	-1135.281	/	( (4247.857	+	2675.533)	/ 2 )
	=	-1135.281	/	3461.695
	=	-32.80 %

Hebei Changshan Biochemical Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	168.504	/	( ( (4775.111 - 2333.413)	+	(4686.232 - 1974.421) )	/ 2 )
	=	168.504	/	( ( 2441.698	+	2711.811 )	/ 2 )
	=	168.504	/	2576.7545
	=	6.54 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hebei Changshan Biochemical Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines